Literature DB >> 27719835

Stress, childhood trauma, and cognitive functions in functional neurologic disorders.

K Roelofs1, J Pasman2.   

Abstract

Conversion disorder (CD) has traditionally been ascribed to psychologic factors such as trauma, stress, or emotional conflict. Although reference to the psychologic origin of CD has been removed from the criteria list in DSM-5, many theories still incorporate CD as originating from adverse events. This chapter provides a critical review of the literature on stressful life events in CD and discusses current cognitive and neurobiologic models linking psychologic stressors with conversion symptomatology. In addition, we propose a neurobiologic stress model integrating those cognitive models with neuroendocrine stress research and propose that stress and stress-induced changes in hypothalamus-pituitary-adrenal (HPA) axis function may result in cognitive alterations, that in turn contribute to experiencing conversion symptoms. Experimental studies indeed suggest that basal as well as stress-induced changes in HPA axis responding lead to alterations in attentional processing in CD. Although those changes are stronger in traumatized patients, similar patterns have been observed in patients who do not report a history of traumatic events. We conclude that, whereas adverse events may play an important role in many cases of CD, a substantial proportion of patients do not report a history of traumatization or recent stressful events. Studies integrating effects of stress on cognitive functioning in CD are scarce. We propose that, instead of focusing research on defining etiologic events in terms of symptom-eliciting events, future research should work towards an integrated mechanistic account, assessing alterations in cognitive and biologic stress systems in an integrated manner in patients with CD. Such an account may not only serve early symptom detection, it might also provide a starting point for better-targeted interventions.
© 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  attention; conversion disorder; functional neurological disorders; life events; mental representations; neurobiologic stress systems; predictions; priors; psychogenic; psychogenic neurological disorders; trauma

Mesh:

Year:  2016        PMID: 27719835     DOI: 10.1016/B978-0-12-801772-2.00013-8

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN: 0072-9752


  5 in total

1.  Hepatic and hippocampal cytochrome P450 enzyme overexpression during spontaneous recurrent seizures.

Authors:  Leonie Runtz; Benoit Girard; Marion Toussenot; Julie Espallergues; Alexis Fayd'Herbe De Maudave; Alexandre Milman; Frederic deBock; Chaitali Ghosh; Nathalie C Guérineau; Jean-Marc Pascussi; Federica Bertaso; Nicola Marchi
Journal:  Epilepsia       Date:  2017-11-10       Impact factor: 5.864

2.  Gender as a Risk Factor for Functional Movement Disorders: The Role of Sexual Abuse.

Authors:  Isaiah Kletenik; Stefan H Sillau; Sanaz Attaripour Isfahani; Kathrin LaFaver; Mark Hallett; Brian D Berman
Journal:  Mov Disord Clin Pract       Date:  2019-12-13

3.  Somatoform dissociation and posttraumatic stress syndrome - two sides of the same medal? A comparison of symptom profiles, trauma history and altered affect regulation between patients with functional neurological symptoms and patients with PTSD.

Authors:  Johanna Kienle; Brigitte Rockstroh; Martin Bohus; Johanna Fiess; Silke Huffziger; Astrid Steffen-Klatt
Journal:  BMC Psychiatry       Date:  2017-07-11       Impact factor: 3.630

Review 4.  Processing of Emotion in Functional Neurological Disorder.

Authors:  Petr Sojka; Martin Bareš; Tomáš Kašpárek; Miroslav Světlák
Journal:  Front Psychiatry       Date:  2018-10-05       Impact factor: 4.157

Review 5.  Subjective versus objective measures of distress, arousal and symptom burden in patients with functional seizures and other functional neurological symptom disorder presentations: A systematic review.

Authors:  Joy Adewusi; Liat Levita; Cordelia Gray; Markus Reuber
Journal:  Epilepsy Behav Rep       Date:  2021-11-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.